Since its incorporation in September 2013 – the Board governs IDHDP. The Board is comprised of seven highly qualified members who are listed below.

 Dr Judith Yates

Yudit Yates        Dr Judith Yates has been a family doctor near the centre of Birmingham UK, for thirty years, specialising in working with people who use drugs and alcohol and over the last two years she has worked in a residential detox unit.

Judith has played a key role in advocating for the provision of take home Naloxone.  She has been part of a Naloxone Steering Group, which has extended the provision of take-home Naloxone across Birmingham. Judith is a founding member of the Independent Consortium on Drug Consumption Rooms and supports harm reduction measures which reduce morbidity associated with the use of drugs and alcohol.

 

Sidney H. Schnoll, M.D., Ph.D.

Sidney H. Schnoll, M.D., Ph.D., is an internationally recognized expert in addiction and pain management.  Sid was a member of the team that developed the Tramadol Independent Steering Committee (ISC), and he was the principal investigator on the health care professional surveillance project to determine rates of abuse of tramadol among health professionals.  Sid also developed the RADARS® System to study the abuse and diversion of prescription opioids, which was cited by the FDA as a model risk management program.    Sid has served on numerous committees and boards including the FDA’s Drug Abuse Advisory Committee (DAAC), NIH study sections, National Board of Medical Examiners test development committees, and was a board member of the College on Problems of Drug Dependence (CPDD).  He has received numerous awards including listings in The Best Doctors in America and is a Fellow of CPDD and the American Society of Addiction Medicine.      With over thirty years in academic medicine, Sid has published over 150 research papers, book chapters and educational materials.  His areas of research include both addiction and pain management with special emphasis on perinatal addiction and prescription drug abuse.
       
Schnoll _pic -2

 

Willem Scholten 

Willem _Scholten _pic
                                                       
Willem Scholten is a Consultant - Medicines and Controlled Substances based in the Netherlands. His specialties are pharmaceutical regulatory affairs and drug control policies, with a special interest in realizing access to adequate pain management for those 5 billion people who have no access. He is a pharmacist who also holds a masters in public administration. He worked for 10 years in retail pharmacy and for 21 years in public administration. In the Ministry of Health of the Netherlands he worked on cost containment of medicines and substance control legislation. He was also the first Head of the Office of Medicinal Cannabis of the Ministry, where he set up the production and distribution of a pharmaceutical quality medicinal cannabis. He joined the World Health Organization in 2005 where he worked on substance evaluation and access to controlled medicines.  He has published over 80 scientific articles and book chapters, including a number of WHO Guidelines that were prepared under his responsibility.

 

 Rakesh Bhasin

Rakesh Bhasin is a Solicitor and a Higher court advocate. He has practised in the field of criminal law for over 17 years. During that time he has represented numerous clients who have been involved with drugs including importation, supplying and using.

Rakesh has represented a number of clients who suffer the effects of historic drug use, some of whom are trying to rehabilitate, and most of whom continue to circulate through the criminal justice system despite their best intentions and efforts. Rakesh is a partner at STEEL & SHAMASH
  

   Rakesh    

 

 

Professor Graham Foster

Screen Shot 2014-03-03 At 00.31.24

Professor Foster is the Professor of Hepatology at Queen Marys University of London and a consultant hepatologist at Barts Health in East London. He has a long standing interest in chronic viral hepatitis and leads a number of national and international clinical trials evaluating new approaches to therapy. He runs clinical and laboratory research programs studying the pathophysiology and virology of hepatitis C.  Graham is involved in pioneering schemes to ensure that those who actively use illicit drugs have equal access to all necessary health care and he leads a team providing community access to drug users afflicted by viral hepatitis.

 

   

Professor Averil Mansfield

Prof Avril

After graduating from the University of Liverpool Professor Mansfield  trained as a surgeon and became a Fellow of The Royal College of Surgeons. She specialised in vascular surgery and worked as a consultant in Liverpool and later in London. 

Averil became Professor of Surgery at St Mary's Hospital, Imperial College and was a member of the Council of the Royal College of Surgeons and also its vice president.  She was was President of the Association of Surgeons of Great Britain & Ireland and President of the Vascular Surgical Society.  After retiring, Averil became the Chairman of the Stroke Association for five years and then the President of the BMA where she went on to take on the role of chairmanship of the BMA’s Board of Science. It was during this appointment that she was responsible for the report entitled “Drugs of Dependence. The role of the medical profession."

 Professor Carl Hart

Carl Hart is an associate professor of psychology at Columbia University, a member of the National Advisory Council on Drug Abuse, and the director of the Methamphetamine Research Laboratories at the New York State Psychiatric Institute. His research focuses on the neuropsychopharmacological effects of psychoactive drugs in humans. In 2013, he published his best-selling book, “High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society.” High Price was the 2014 winner of the PEN/E.O. Wilson Literary Science Writing Award.    

CARL_PIC (3)
Share this on: